Drug Profile


Alternative Names: 2-Carboxyethylgermanium sesquioxide; GE 132; Rexagermanium

Latest Information Update: 22 Feb 1999

Price : $50

At a glance

  • Originator Asai Germanium
  • Class Heavy metals
  • Mechanism of Action Glycosylation inhibitors; Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Cancer; Cataracts; Postmenopausal osteoporosis

Most Recent Events

  • 22 Feb 1999 GE 132 is now called repagermanium
  • 27 Jan 1999 Discontinued-Preclinical for Cataracts in USA (Unknown route)
  • 27 Jan 1999 Discontinued-Preclinical for Postmenopausal osteoporosis in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top